Doctor Turns Baby's Death Into FDA-Approved Treatment

A baby died in Dr. Kevin Tracey's arms in 1985, and he couldn't shake the question: why? Eleven-month-old Janice survived severe burns for a month before her body suddenly shut down, leaving Tracey haunted by nightmares and driven by one mission.

That devastating loss launched a 40-year quest that just reached the finish line. In July 2025, the FDA approved Tracey's invention: a tiny device that controls inflammation by sending electrical signals through the body's nervous system.

The SetPoint System is about the size of a multivitamin. Doctors implant it on the vagus nerve in the neck, where it delivers one minute of electrical stimulation each day to calm an overactive immune system.

For people with rheumatoid arthritis, that one minute changes everything. About 1.5 million Americans live with RA, a disease that causes the immune system to attack the body's own joints, creating painful swelling and chronic exhaustion that can make getting out of bed feel impossible.

Traditional medications help some patients, but they often cause brain fog and weaken the immune system. Many people run out of options entirely.

Jessica Hancock was one of those patients. She suffered through more than a dozen years of debilitating pain starting in her mid-30s, trapped in a body that felt 90 years old.

The device was born from an accidental lab discovery and a sketch on a napkin. Tracey never imagined it would take 27 years from that 1998 breakthrough to FDA approval, but he never gave up.

Why This Inspires

Tracey's story proves that one person refusing to accept "that's just how it is" can change medicine for millions. He could have moved on from that terrible night in 1985, but instead he let his heartbreak fuel discovery.

The approved device treats rheumatoid arthritis today, but Tracey sees much bigger possibilities ahead. If electrical signals can control inflammation in joints, why not in hearts, or to prevent cancer?

His team already proved the device is safe and effective in a 242-patient trial. Now Tracey is asking the next question: what if we could stop inflammation before it ever causes disease?

TIME named him one of 2025's top 100 health innovators, but Tracey insists he's just getting started. "Some people think science is about honor societies and prizes," he said. "I think it's about patients."

When Tracey meets people whose lives changed because of his lab work, he lights up with joy. That feeling drives him forward, even after four decades.

Baby Janice didn't survive, but her death sparked a revolution in medicine that's only beginning to unfold.